CD4

Chr 12

CD4 molecule

Also known as: CD4mut, IMD79, Leu-3, OKT4D, T4

This gene encodes the CD4 membrane glycoprotein of T lymphocytes. The CD4 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class II MHC molecules. The CD4 antigen is also a primary receptor for entry of the human immunodeficiency virus through interactions with the HIV Env gp120 subunit. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, granulocytes, as well as in various regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, May 2020]

GeneReviewsResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

UniProtImmunodeficiency 79
12
Active trials
13979
Pubs (1 yr)
P/LP submissions
P/LP missense
0.71
LOEUF
Multiple*
Mechanism· predicted
📖
GeneReview available — CD4
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.71LOEUF
pLI 0.001
Z-score 2.59
OE 0.41 (0.240.71)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.06Z-score
OE missense 0.81 (0.720.91)
206 obs / 253.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.41 (0.240.71)
00.351.4
Missense OE?0.81 (0.720.91)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 9 / 22.1Missense obs/exp: 206 / 253.3Syn Z: 0.34

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CD4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Diabetes, Type I

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

NOT YET RECRUITING
NCT06938334Phase PHASE1, PHASE2Altheia ScienceStarted 2025-08-15
Autologous CD34+ cell enriched population containing HSPCs transduced ex vivo using a LVV encoding the hPD-L1 DNA
Haematologic Disease

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

RECRUITING
NCT04180059Phase PHASE1Nantes University HospitalStarted 2020-02-09
CTL 19
Severe Combined Immunodeficiency (SCID)Leaky SCIDOmenn Syndrome

Natural History Study of SCID Disorders

ENROLLING BY INVITATION
NCT01186913National Institute of Allergy and Infectious Diseases (NIAID)Started 2010-09-02
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial

ACTIVE NOT RECRUITING
NCT05514990Phase PHASE1, PHASE2University of Southern CaliforniaStarted 2022-10-07
BortezomibDexamethasonePelareorep
Pre-FrailtyAging

Exploratory Study on a Multi-nutrient Supplement and Exercise Program for Improving Health Markers Associated to Longevity in Pre-frail Adults

RECRUITING
NCT07454616Phase NANational University of SingaporeStarted 2025-09-22
Supervised exercise programa balanced micronutrient blend
Immunologic Deficiency Syndromes

Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)

ENROLLING BY INVITATION
NCT03478670Fondazione TelethonStarted 2017-05-05
Strimvelis
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

RECRUITING
NCT07194980Phase PHASE2Fred Hutchinson Cancer CenterStarted 2026-09-01
NemtabrutinibLisocabtagene Maraleucel
Infant, NewbornImmunityImmunisation

The Bloom Infant Probiotic (BIP) Study

RECRUITING
NCT07189390Phase PHASE2South Australian Health and Medical Research InstituteStarted 2026-05-25
ProbioticMatching placebo
B-cell NHLCLL

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

RECRUITING
NCT05869279Phase PHASE1, PHASE2Fondazione Matilde Tettamanti Menotti De Marchi OnlusStarted 2023-12-01
CARCIK-CD19
Prostate Cancer

Pembro With Radiation With or Without Olaparib

RECRUITING
NCT05568550Phase PHASE2Zin W MyintStarted 2023-07-27
PembrolizumabOlaparibAndrogen Deprivation Therapy
Immune System ToleranceDepressionObesity

ESAN II - Energy Sensing in Depression

RECRUITING
NCT05432362Phase NAMedical University of GrazStarted 2019-02-25
Aronia JuicePlacebo
AIDS-related Non-Hodgkin LymphomaAIDS-related Plasmablastic LymphomaAIDS-related Primary Effusion Lymphoma

Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

ACTIVE NOT RECRUITING
NCT01961063Phase PHASE1City of Hope Medical CenterStarted 2015-12-31
busulfanlentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cellspharmacological study